Anti-ZMYND10 monoclonal antibody
Pre-made anti-ZMYND10 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research
Go to ZMYND10/ZMYND10 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-IP2820-Ab-1/ GM-Tg-hg-IP2820-Ab-2 | Anti-Human ZMYND10 monoclonal antibody | Human |
GM-Tg-rg-IP2820-Ab-1/ GM-Tg-rg-IP2820-Ab-2 | Anti-Rat ZMYND10 monoclonal antibody | Rat |
GM-Tg-mg-IP2820-Ab-1/ GM-Tg-mg-IP2820-Ab-2 | Anti-Mouse ZMYND10 monoclonal antibody | Mouse |
GM-Tg-cynog-IP2820-Ab-1/ GM-Tg-cynog-IP2820-Ab-2 | Anti-Cynomolgus/ Rhesus macaque ZMYND10 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-IP2820-Ab-1/ GM-Tg-felg-IP2820-Ab-2 | Anti-Feline ZMYND10 monoclonal antibody | Feline |
GM-Tg-cang-IP2820-Ab-1/ GM-Tg-cang-IP2820-Ab-2 | Anti-Canine ZMYND10 monoclonal antibody | Canine |
GM-Tg-bovg-IP2820-Ab-1/ GM-Tg-bovg-IP2820-Ab-2 | Anti-Bovine ZMYND10 monoclonal antibody | Bovine |
GM-Tg-equg-IP2820-Ab-1/ GM-Tg-equg-IP2820-Ab-2 | Anti-Equine ZMYND10 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-IP2820-Ab-1/ GM-Tg-hg-IP2820-Ab-2; GM-Tg-rg-IP2820-Ab-1/ GM-Tg-rg-IP2820-Ab-2; GM-Tg-mg-IP2820-Ab-1/ GM-Tg-mg-IP2820-Ab-2; GM-Tg-cynog-IP2820-Ab-1/ GM-Tg-cynog-IP2820-Ab-2; GM-Tg-felg-IP2820-Ab-1/ GM-Tg-felg-IP2820-Ab-2; GM-Tg-cang-IP2820-Ab-1/ GM-Tg-cang-IP2820-Ab-2; GM-Tg-bovg-IP2820-Ab-1/ GM-Tg-bovg-IP2820-Ab-2; GM-Tg-equg-IP2820-Ab-1/ GM-Tg-equg-IP2820-Ab-2 |
Products Name | Anti-ZMYND10 monoclonal antibody |
Format | mab |
Target Name | ZMYND10 |
Protein Sub-location | Introcelluar Protein |
Category of antibody | |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected. |
Tag | Fc |
Products description | Pre-made anti-ZMYND10 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | GM-Tg-g-IP2820-Ag-1 | Recombinant multi-species ZMY10/ ZMYND10/ BLU protein |
ORF Viral Vector | vGMLV000114 | human ZMYND10 Lentivirus particle |
ORF Viral Vector | pGMLV000114 | human ZMYND10 Lentivirus plasmid |
ORF Viral Vector | pGMLPm001648 | mouse Zmynd10 Lentivirus plasmid |
ORF Viral Vector | vGMLPm001648 | mouse Zmynd10 Lentivirus particle |
Target information
Target ID | GM-IP2820 |
Target Name | ZMYND10 |
Gene ID | 51364,114602,363139,702678,476615,101094912,528799,100146221 |
Gene Symbol and Synonyms | BLU,CILD22,DNAAF7,FLU,ZMYND10 |
Uniprot Accession | O75800,Q6AXZ5 |
Uniprot Entry Name | ZMY10_HUMAN,ZMY10_RAT |
Protein Sub-location | Introcelluar Protein |
Category | |
Disease | Cancer |
Gene Ensembl | ENSG00000004838 |
Target Classification | Tumor-associated antigen (TAA) |
The target: ZMYND10, gene name: ZMYND10, also named as BLU, CILD22, DNAAF7, FLU. This gene encodes a protein containing a MYND-type zinc finger domain that likely functions in assembly of the dynein motor. Mutations in this gene can cause primary ciliary dyskinesia. This gene is also considered a tumor suppressor gene and is often mutated, deleted, or hypermethylated and silenced in cancer cells. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.